Literature DB >> 23983834

Status epilepticus: current treatment strategies.

Edward M Manno1.   

Abstract

Status epilepticus is a neurological emergency that is commonly encountered by the neurohospitalist. Successful treatment depends upon the recognition of prolonged seizure activity and the acute mobilization of available resources. Pharmacologic treatment regimens have been shown to decrease the time needed for successful control of seizures and have provided for the rapid administration of anticonvulsant medications. Treatment strategies have evolved so that clinicians can administer effective doses of medication by whatever routes of administration are immediately available. Traditional algorithms for the treatment of status epilepticus have used a stepwise approach to the administration of first-, second-, and third-order medications. More recent options have included aggressive anesthetic doses of medications while second-line medications are being titrated.

Entities:  

Keywords:  neurological emergencies; seizures; status epilepticus

Year:  2011        PMID: 23983834      PMCID: PMC3726103          DOI: 10.1177/1941875210383176

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  62 in total

Review 1.  Management of major status epilepticus in adults.

Authors:  M D O'Brien
Journal:  BMJ       Date:  1990-10-20

2.  Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring.

Authors:  P M Vespa; M R Nuwer; V Nenov; E Ronne-Engstrom; D A Hovda; M Bergsneider; D F Kelly; N A Martin; D P Becker
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

Review 3.  Status epilepticus-induced neuronal injury and network reorganization.

Authors:  R S Sloviter
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

Review 4.  Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 5.  Pharmacology and pharmacokinetics of fosphenytoin.

Authors:  T R Browne; A R Kugler; M A Eldon
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

6.  The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus.

Authors:  James W Wheless; David M Treiman
Journal:  Epilepsia       Date:  2008-12       Impact factor: 5.864

7.  Status epilepticus at an urban public hospital in the 1980s.

Authors:  D H Lowenstein; B K Alldredge
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

8.  Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin.

Authors:  R Gilad; N Izkovitz; R Dabby; A Rapoport; M Sadeh; B Weller; Y Lampl
Journal:  Acta Neurol Scand       Date:  2008-11       Impact factor: 3.209

9.  Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin.

Authors:  T J O'Brien; G D Cascino; E L So; D R Hanna
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

10.  Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action.

Authors:  D J Greenblatt; M Divoll
Journal:  Adv Neurol       Date:  1983
View more
  8 in total

Review 1.  Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy.

Authors:  Shaunik Sharma; Sreekanth Puttachary; Thimmasettappa Thippeswamy
Journal:  J Neurosci Res       Date:  2017-12-12       Impact factor: 4.164

2.  Oxidative Stress Contributes to Status Epilepticus Associated Mortality.

Authors:  Jennifer N Pearson-Smith; Li-Ping Liang; Shane D Rowley; Brian J Day; Manisha Patel
Journal:  Neurochem Res       Date:  2017-05-02       Impact factor: 3.996

3.  Antiseizure and neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure.

Authors:  Jay Spampanato; Wendy Pouliot; Steven L Bealer; Bonnie Roach; Francis Edward Dudek
Journal:  Epilepsia       Date:  2019-05-24       Impact factor: 6.740

Review 4.  Astroglial role in the pathophysiology of status epilepticus: an overview.

Authors:  Karina Vargas-Sánchez; Maria Mogilevskaya; John Rodríguez-Pérez; María G Rubiano; José J Javela; Rodrigo E González-Reyes
Journal:  Oncotarget       Date:  2018-06-01

Review 5.  First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines.

Authors:  Marios Charalambous; Holger A Volk; Luc Van Ham; Sofie F M Bhatti
Journal:  BMC Vet Res       Date:  2021-03-04       Impact factor: 2.741

6.  In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus.

Authors:  Somayeh Taymouri; Mohsen Minaiyan; Farnaz Ebrahimi; Naser Tavakoli
Journal:  IET Nanobiotechnol       Date:  2020-04       Impact factor: 1.847

Review 7.  Status Epilepticus: Behavioral and Electroencephalography Seizure Correlates in Kainate Experimental Models.

Authors:  Shaunik Sharma; Sreekanth Puttachary; Achala Thippeswamy; Anumantha G Kanthasamy; Thimmasettappa Thippeswamy
Journal:  Front Neurol       Date:  2018-01-23       Impact factor: 4.003

8.  Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model.

Authors:  Asheebo Rojas; Wenyi Wang; Avery Glover; Zahra Manji; Yujiao Fu; Raymond Dingledine
Journal:  eNeuro       Date:  2018-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.